期刊文献+

CYP2C19显色型基因芯片的研究 被引量:1

Study of colorful gene chip for CYP2C19 genotyping
下载PDF
导出
摘要 目的提供一种基于显色原理的CYP2C19基因芯片诊断方法。方法采用碱性磷酸酶促显色原理设计制备固定有*2、*3检测探针的CYP2C19基因芯片,通过EDTA抗凝外周血样本提取基因组DNA,PCR扩增CYP2C19*2、*3突变片段并与芯片在43℃杂交,经洗涤、显色后扫描获取图像,经软件分析输出基因型并对基因芯片性能进行系统评价。结果 CYP2C19显色型基因芯片检出限为20 ng基因组DNA;与基因组DNA同等浓度鱼精DNA检测信号阴性;用*2/*2、*1/*3基因型样本重复检测10次,结果一致;常见浓度的甘油三酯、总胆固醇、胆红素和完全溶血对测定没有影响。临床三家医院临检实验室对1000例临床样本的检测与双向测序方法比对验证,结果一致。结论为高通量基因诊断产品的产业化提供了一种实用的技术选择。 Objective Gene microarray as a new kind of genetic diagnosis technology has been applied in clinical examination. Currently, probe-target hybridization is usually detected and quantified by detection of fluorophore with several shortages, such as raw materials, expensive testing equipment and unstable detection signal. Here, we try to build a method detected by coloration for quickly detecting the genotypes of CYP2C19. Methods Genomic DNA is extracted from peripheral blood samples anticoagulated with EDTA. The DNA fractions were amplified by PCR and hybridized with the probes of CYP2C19*2 and CYP2C19*3 mutant alleles on the CYP2C19 gene chip on 43℃. After washing and developing the gene chip, the hybridization results were observed through gene chip scanning machine with Arraydoctor2.0 software. Results The detection limit of CYP2C19 colorful gene chip is 20 ng genomic DNA; Negative control groups which is hybridized with equal concentration of Salmon sperm DNA show no bands; The measurement of samples of*2/*2,*1/*3 genotype alleles are repeated 10 times and the results are also consistent. Triglyceride, cholesterol, bilirubin and hemolysis which are contained in blood samples have no influence to the results. 1000 clinical samples were detected by clinical laboratory from three hospitals. The detection results from gene chip were same as sequencing results. Conclusion Our study provides a technological meaning for clinical application using high-throughput gene detection related to personalized medicine.
出处 《中国医药生物技术》 2015年第1期39-44,共6页 Chinese Medicinal Biotechnology
基金 上海市科技型中小企业创新基金(1202H133200) 上海市徐汇区高新技术产业项目(创新类)(2014010033)
关键词 芯片分析技术 多态性 单核苷酸 基因分型技术 Microchip analytical procedures Polymorphism, single nucleotide Genotyping techniques CYP2C19
  • 相关文献

参考文献10

  • 1Promyslov MSh, Kapytovskaia IN. Several methodolic features ofdetermining cerebral gamma-aminobutyric acid. Vopr Med Khim,1977(1):139-141.
  • 2Kim IJ,Kang HC, Park JH, et al. RET oligonucleotide microarray forthe detection of RET mutations in multiple endocrine neoplasia type 2syndromes. Clin Cancer Res, 2002, 8(2):457-463.
  • 3Debouck C, Goodfellow PN. DNA microarrays in drug discovery anddevelopment. Nat Genet, 1999, 21(1 Suppl):48-50.
  • 4周健,吕虹,康熙雄.药物代谢酶CYP2D6和CYP2C19的基因多态性与个体化治疗[J].中国医药生物技术,2009,4(4):299-302. 被引量:17
  • 5王谦,杜亚梅,张国军,康熙雄.焦磷酸测序法与Sanger测序法检测CYP2C19*17基因多态性方法学对比研究[J].中国医药生物技术,2014,9(3):222-224. 被引量:5
  • 6de Morais SM, Wilkinson GR,Blaisdell J, et al. The major geneticdefect responsible for the polymorphism of S-mephenytoinmetabolism in humans. J Biol Chem, 1994,269(22):15419-15422.
  • 7de Morais SM, Wilkinson GR, Blaisdell J, et al. Identification of anew genetic defect responsible for the polymorphism of(S)-mephenytoin metabolism in Japanese. Molecular Pharmacol, 1994,46(4):594-598.
  • 8Liu Q, Dang DS,Chen YF, et al. The influence of omeprazole onplatelet inhibition of clopidogrel in various CYP2C19 mutant alleles.Genet Test Mol Biomarkers, 2012, 16(11):1293-1297.
  • 9Liu Y, Liu N, Li W, et al. Relationship of CYP2C19*2 andCYP2C19*3 gene polymorphism with clopidogrel response variabilityand recurrent cardiovascular events in Chinese patients undergoingpercutaneous coronary intervention. Pharmacology, 2013, 91(3-4):165-172.
  • 10Lozano-Ortiz R, Marin-Lacasa R, Pascual-Garcia A, et al. Therapeuticmonitoring of escitalopram by dexamethasone suppression test. ActasEsp Psiquiatr, 2012,40(5):275-280.

二级参考文献16

  • 1Pestka EL, Hale AM, Johnson BL, et al. Cytochrome P450 testing for better psychiatric care. J Psychosoc Nurs Merit Health Serv, 2007, 45(10):15-18.
  • 2Jiang D, Bai X, Zhang Q, et al. Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling. Eur J Clin Pharmacol, 2009, 65(12): 1187-1193.
  • 3Hunfeld NG, Touw DJ, Mathot RA, et al. A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism. Aliment Pharmacol Ther, 2010, 31(1):150-159.
  • 4Yu BN, Chen GL, He N, et al. Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19. Drug Metab Dispos, 2003, 31(10):1255-1259.
  • 5Ma TK, Lam YY, Tan VP, et al. Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel. Pharmacol Ther, 2010, 125(2):249-259.
  • 6Marqulies M, Eqholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature, 2005, 437(7057):376-380.
  • 7Xie X, Ma YT, Yang YN, et al. Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: a randomized control trial. Int J Cardiol, 2013, 168(4): 3736-3740.
  • 8Spokoyny I, Barazangi N, Jaramillo V, et al. Reduced clopidogrel metabolism in a multiethnic population: prevalence and rates of recurrent cerebrovascular events. J Stroke Cerebrovasc Dis, 2014, 23(4):694-698.
  • 9Sim SC, Risinger C, Dahl ML, et al. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther, 2006, 79( 1 ): 103-113.
  • 10Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Eng J Med, 2013, 369(1): 11-19.

共引文献20

同被引文献13

  • 1王树文,闫成新,张天序,赵广州.数学形态学在图像处理中的应用[J].计算机工程与应用,2004,40(32):89-92. 被引量:200
  • 2胡园园,孙啸,何农跃,汤建新.基于图像投影的基因芯片图像网格定位[J].生物医学工程学杂志,2005,22(4):668-671. 被引量:9
  • 3张帆,薛利军,李自田,吴小华.基于CCD的生物芯片扫描分析系统的设计[J].光子学报,2006,35(4):565-568. 被引量:4
  • 4张文毓.生物芯片产业发展现状及展望[J].传感器世界,2007,13(10):6-10. 被引量:5
  • 5RACHI.IN D J. Optimized approach for microarray scanning [J]. ProcSHE, 2002, 4623:7- 13.
  • 6国家食品药品监督管理总局,国家食品药品监督管理总局数据库[DB/OL].(2014-10-26)[2015-10-10].http://appl.sf-da.gov.cn/datasearch/face3/dir.html.
  • 7BAJCSY P. An overview of DNA microarray image require- ments for automated processing [C]// IEEE Computer Socie- ty Conference on Computer Vision and Pattern Recognition. San Diego, CA, USA: 2005: 147.
  • 8FENSTERMACHER D. Introduction to bioinformatics [J]. Journal of the American Society for Information Science and Technology, 2005, 56(5): 440-446.
  • 9GONZALEZ R C, WOODS R E. Digital image processing [M]. 2nd ed. Beiiing: Publishing House of Electronics Indus- try, 2003.
  • 10PETERS R A. A new algorithm for image noise-reduction u- sing mathematical morphology [J]. IEEE Transactions on Image Processing, 1995, 4(5) : 554-568.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部